SiTime to Present at Upcoming Financial Conferences
SANTA CLARA, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) — SiTime Corporation (Nasdaq: SITM), a market leader in MEMS timing, today […]
Gaia Reports Fourth Quarter and Full Year 2019 Results
Positive EBITDA and Cash Flows from Operations for Q4 29% Revenue Growth for 2019BOULDER, Colo., Feb. 24, 2020 (GLOBE NEWSWIRE) — […]
UNITY Biotechnology, Inc. to Participate in the Cowen and Company 40th Annual Health Care Conference
SAN FRANCISCO, Feb. 24, 2020 (GLOBE NEWSWIRE) — UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend […]
LPL Financial Reports Monthly Activity for January 2020
SAN DIEGO, Feb. 24, 2020 (GLOBE NEWSWIRE) — Leading retail investment advisory firm and independent broker-dealer LPL Financial LLC, a […]
HP Inc. Reports Fiscal 2020 First Quarter Results
PALO ALTO, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) — HP (NYSE: HPQ)Notes to tableInformation about HP Inc.’s use of non-GAAP […]
Steve Brunker Named Hillman Chief Information Officer
CINCINNATI, Feb. 24, 2020 (GLOBE NEWSWIRE) — The Hillman Companies, Inc. (NYSE-AMEX: HLM.PR) and The Hillman Group, Inc. (collectively, “Hillman” […]
Merit Medical Reports Earnings for Fourth Quarter and Year Ended December 31, 2019, Gives FY 2020 Guidance
Q4 2019 worldwide revenue of $257.9 million, up 10.6% as reported over Q4 2018Q4 2019 core revenue on a comparable, […]
Guardant Health Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Full Year 2020 Outlook
REDWOOD CITY, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) — Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused […]
Axogen, Inc. Reports Fourth Quarter and Full-Year 2019 Financial Results
ALACHUA, Fla., Feb. 24, 2020 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative […]
Opiant Pharmaceuticals to Report Fourth Quarter 2019 Financial Results and Host Conference Call and Webcast on Wednesday, March 4
SANTA MONICA, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing […]
